OUR SCIENCE

Our science is pioneering the development of MotionTx platform, a new modality of therapeutic entities with unique properties to penetrate tissues and accumulate in target cells. 

New Modality

Novel class of therapies with unique tissue penetration capabilities

Platform Technology

Can carry a variety of drugs for different therapeutic indications

Targeted Delivery

Maximizing local routes of administration

Our Proof-of-Concept is focused on bladder cancer

NBT-102

Undisclosed indication